Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Search
Who we are
How to use and read
Pharma World
Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Home
EIPG Newsletter
Regulatory
Regulatory
EMA’s vision on evidence by design to evaluate the added therapeutic...
Giuliana Miglierini
-
15 May 2019
0
The EURIPID Collaboration for pricing and reimbursement
Giuliana Miglierini
-
16 April 2019
0
EMA’s first guideline on medical devices integral to medicinal products
Giuliana Miglierini
-
21 March 2019
0
Consultation on the future of Regulatory Sciences to 2025
Giuliana Miglierini
-
20 February 2019
0
New Q&As on safety features from the EU Commission
Giuliana Miglierini
-
15 January 2019
0
EMA opened a consultation on the use of patient registries for...
Giuliana Miglierini
-
11 December 2018
0
The use of real world data for R&D of pharmaceuticals
Giuliana Miglierini
-
21 November 2018
0
Brexit: EU Commission warns on possible issues regarding clinical trials
Giuliana Miglierini
-
23 October 2018
0
Regulators launched activities to prepare for the Brexit
Giuliana Miglierini
-
20 September 2018
0
Pharma companies are not yet ready for the Brexit
Giuliana Miglierini
-
2 August 2018
0
1
2
Page 1 of 2
